Exane Derivatives’s JetBlue JBLU Stock Holding History

Exane Derivatives’s Portfolio JBLU Stock Details JBLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$20	–	712
2018 Q3	$20	Hold	1	–	–	﹤0.01%	676
2018 Q2	$19	Hold	1	–	–	﹤0.01%	668
2018 Q1	$20	Hold	1	–	–	﹤0.01%	606
2017 Q4	$22	Sell	1 -4,037	-100%	-$82.5K	﹤0.01%	591
2017 Q3	$74.8K	Buy	+4,038	New	+$84.6K	0.01%	283
2017 Q2	–	Sell	-1,615	Closed	-$33.3K	–	659
2017 Q1	$33.3K	Buy	1,615 +246	+18%	+$5.02K	0.01%	292
2016 Q4	$30.7K	Sell	1,369 -6,654	-83%	-$131K	0.01%	334
2016 Q3	$138K	Buy	8,023 +1,400	+21%	+$23.9K	0.02%	220
2016 Q2	$110K	Buy	6,623 +4,200	+173%	+$78K	0.02%	238
2016 Q1	$51.2K	Buy	+2,423	New	+$51K	0.01%	307

Other funds holding JBLU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Exane Derivatives's JBLU Position: Q4 2018 in Review

Exane Derivatives sold out of JetBlue (JBLU) in Q4 2018, closing a stake of 1 share — an estimated $20 sold.

Exane Derivatives first reported a position in JBLU in Q1 2016 and held it in 10 quarters. The position peaked at $138K in Q3 2016. 360 funds tracked by Wall St. Rank hold JBLU as of Q4 2018.

Exane Derivatives reported no remaining JetBlue position as of Q4 2018 after selling out during the quarter.
Exane Derivatives sold 1 JetBlue share in Q4 2018, an estimated $20.
Exane Derivatives first reported a position in JetBlue in Q1 2016 and held it in 10 quarters.
Exane Derivatives's JetBlue position peaked at $138K in Q3 2016.
360 funds tracked by Wall St. Rank held JetBlue as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.